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Molecular cloning and expression of bovine
nucleoplasmin 2 (NPM2): a maternal effect
gene regulated by miR-181a
Brandon M Lingenfelter1,5, Swamy K Tripurani1, Jyothsna Tejomurtula1, George W Smith2,3,4 and Jianbo Yao1*

Abstract
Background: Nucleoplasmin 2 (NPM2) is an oocyte-specific nuclear protein essential for nuclear and nucleolar
organization and early embryonic development. The aims of this study were to clone the bovine NPM2 gene,
determine its temporal expression during oocyte development and early embryogenesis, and evaluate the
potential role of miRNA-181a in regulation of its expression.
Methods: A 329 bp cDNA fragment was amplified from bovine fetal ovary using primers designed based on the
conserved regions of the human and mouse NPM2 cDNA sequences. RACE experiments were performed to obtain
the 5’ and 3’ ends of the bovine NPM2 cDNA. Real time PCR and Western blot analysis were used to examine the
expression of bovine NPM2 in oocytes and early embryos. Co-expression of bovine NPM2 and miRNA-181a in Hela
cells was performed to determine if expression of bovine NPM2 is regulated by miRNA-181a.
Results: The bovine NPM2 cDNA is 851 bp in length encoding a protein of 200 amino acids. The protein contains
the conserved bipartite nuclear localization sequence and shows 53% and 62% identity with mouse and human
NPM2, respectively. Expression of bovine NPM2 mRNA is restricted to ovaries. NPM2 mRNA is abundant in GV and
MII stage oocytes, decreases in early cleavage stage embryos, and barely detectable in morula and blastocyst stage
embryos. Similarly, expression of NPM2 protein is high in oocytes and early embryos but extremely low in
blastocysts. The abundance of NPM2 mRNA is significantly lower in oocytes isolated from persistent versus growing
dominant follicles (P < 0.05). A miR-181a binding site in the 3’UTR of the NPM2 transcript was identified.
Transfection experiments showed that bovine NPM2 protein expression is reduced in Hela cells expressing miR181a compared to control cells without miR-181a, indicating that translation of NPM2 is repressed by miR-181a.
Conclusions: Our data suggest that expression of bovine NPM2 is temporally regulated during early
embryogenesis and miR-181a may play a role in its regulation.

Background
Maternal mRNAs that accumulate in the oocyte during
oogenesis play important roles during initial stages of
embryonic development, before activation of the
embryonic genome [1]. Some of the maternal transcripts
are oocyte-specific and known as maternal effect genes
which are required for the early cleavage events post fertilization [2,3]. Examples of maternal effect genes that
have been identified in mice include maternal antigen

* Correspondence: jianbo.yao@mail.wvu.edu
1
Laboratory of Animal Biotechnology and Genomics, Division of Animal and
Nutritional Sciences, West Virginia University, Morgantown, WV 26506, USA
Full list of author information is available at the end of the article

that embryos require (Mater) [4], zygote arrest 1 (Zar1)
[5] and nucleoplasmin 2 (Npm2) [6].
To ensure formation of a diploid genome after fertilization, maternal and paternal DNA must undergo remodeling. NPM2, an oocyte-specific nuclear factor, plays an
important role in this process. In Xenopus laevis,
nucleoplasmin (NPM) decondenses sperm DNA after its
entry into the oocyte [7,8]. Knockout of NPM2 in mice
reduced initial cleavage of embryos and impaired development to the 2-cell stage, and resulted in fragmentation and asynchrony of further cleavage and death by
50 hr post-fertilization [6]. Microinjection of NPM into
bovine oocytes after nuclear transfer resulted in
increased viability of embryos and higher rate of
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pregnancy [9], suggesting a role for NPM in facilitating
reprogramming of the somatic nucleus.
Degradation of maternal transcripts allows normal
embryonic development [10,11]. Multiple mechanisms
for maternal RNA degradation exist [12] including the
actions of microRNAs (miRNAs). MicroRNAs downregulate gene expression by binding to known miRNAtarget sites on mRNA in the 3’ untranslated region
(3’UTR) [13]. Knockout of Dicer, an enzyme required
for the production of mature miRNAs, results in
increased embryonic death in mice [14,15] and abnormal development in zebrafish [16]. A particular miRNA,
miR-430, has been showed to target several hundred
maternal mRNAs in zebrafish [17].
In domestic animals, major activation of the embryonic genome takes place later as compared to rodents
(e.g. 8-16-cell stage in cattle vs. 2-cell stage in mouse)
suggesting potential species differences in mechanisms
and mediators of the maternal-to-embryonic transition.
To date, bovine orthologues of mouse Mater and Zar1
have been cloned and their expression profiles during
oocyte maturation and early embryogenesis characterized [18-20]. Recently, two novel oocyte-specific genes,
JY-1 and KPNA7, have been discovered in cattle and
their roles in regulating early embryonic development
demonstrated [21,22]. Furthermore, the mechanisms
responsible for characteristic temporal expression pattern of products of specific maternal effect genes during
early embryogenesis are not completely understood. In
this study, we report the cloning of bovine NPM2, its
mRNA and protein expression during oocyte maturation
and early embryonic development and the potential role
of miR-181a in regulation of its expression.

Methods
Tissue collection and RNA isolation

Bovine tissue samples including adult liver, lung, thymus, kidney, muscle, heart, spleen, cortex (brain), pituitary, adrenal, testis, ovary, and fetal testis and ovaries,
were collected at a local slaughterhouse. All samples
were frozen in liquid nitrogen and stored at -80°C until
RNA isolation. Total RNA was isolated from these tissues using TRIzol reagent (Invitrogen, Carlsbad, CA)
and treated with DNase (Promega, Madison, WI)
according to manufacturer’s protocols.
RT-PCR analysis of bovine NPM2 mRNA expression

Total RNA from various bovine tissues was used to generate cDNA using oligo (dT)18 primer and Superscript
III reverse transcriptase (Invitrogen, Carlsbad, CA).
Negative control reactions (without the enzyme) were
carried out to confirm the absence of genomic DNA
contamination. First-strand cDNA was used as a template for PCR amplification of a 329 bp fragment using
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bovine NPM2 gene-specific primers (Additional file 1,
Table S1). The PCR was performed using 35 cycles of
94°C for 30 sec, 59°C for 45 sec and 72°C for 30 sec,
and a final extension at 72°C for 10 min. Bovine ribosomal protein L19 (RPL19) gene was used as a positive
control.
Cloning of bovine NPM2 cDNA by PCR and RACE

PCR primers were designed based on conserved regions
of human (NM_182795) and mouse (NM_181345)
NPM2 sequences to amplify a 329 bp cDNA fragment
from a fetal ovary sample (230 days of gestation). The
product was cloned using TOPO® TA cloning kit (Invitrogen, Carlsbad, CA) and sequenced. Primers for 5’ and
3’RACE were designed based on the obtained bovine
NPM2 cDNA sequence (Additional file 1, Table S1).
RACE experiments were performed to obtain the 5’ and
3’ ends of bovine NPM2 cDNA using the second generation 5’/3’RACE kit (Roche Diagnostics, Indianapolis,
IN) following the manufacturer’s protocol. Total RNA
from bovine fetal ovary was used to generate cDNA
with either a gene-specific primer (5’RACE) or an oligo
d(T)-anchor primer (3’RACE) followed by nested PCR
using gene-specific primers in conjunction with d(T)
anchored primers provided in the kit. The specific PCR
products were cloned using the TOPO® TA cloning kit
(Invitrogen, Carlsbad, CA). The RACE products were
sequenced at the University of Illinois Core DNA
Sequencing Facility (Urbana, IL).
Quantitative real time PCR analysis

Expression of bovine NPM2 mRNA during oocyte
maturation and early embryonic development was determined by real time PCR as described previously [23]
using primers listed in Additional file 1, Table S1. GV
and MII stage oocytes, pronuclear, 2-cell, 4-cell, 8-cell,
16-cell, morula and blastocyst stage embryos (n = 5
pools of 10 each) were obtained by in vitro fertilization
of abattoir derived oocytes as described [23]. Total RNA
from oocytes and embryos was isolated using the RNAqueous®-Micro kit (Ambion Inc., Austin, TX). Spiked
green fluorescent protein (GFP) synthetic RNA was used
as an exogenous control to account for variations in
RNA recovery and efficiency of cDNA synthesis between
samples.
Quantitative real time PCR analysis of bovine NPM2
mRNA expression in oocytes from growing and persistent dominant follicles was performed as described previously [24]. Oocytes from growing (day 6) and
persistent follicles (day 13, estrus = day 0) were used in
this analysis. Total RNA isolated from individual oocytes
was subjected to linear amplification before real time
PCR assay. Bovine HIST2H2AA4 gene (BF076713) was
used as an endogenous control for data normalization as
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expression of this gene does not differ in oocytes from
the two types of follicles [24]. Primers for this gene are
listed in Additional file 1, Table S1.
Quantitative real time PCR analysis of miR-181a
expression in oocytes and early stage embryos was performed as described [25]. miR-125b was used as an
endogenous control to normalize the target miRNA
because this miRNA is expressed consistently in preimplantation mouse embryos [26].
Western blot analysis

Western blot analysis of bovine NPM2 protein expression in oocytes and early embryos was performed as
previously described [22]. The oocyte and embryo samples (50 oocytes/embryos each lane) were purchased
from Bomed Inc. (Madison, WI). The primary antibody
(anti-bovine NPM2) was prepared commercially by GenScript Corporation (Piscataway, NJ). It was generated by
immunizing rabbits with a 15-amino acid synthetic
peptide (ERPTWTFKPQKVGKC, amino acid position
26-39) of bovine NPM2 protein. Unpurified antiserum
from the third bleed was used in the study.
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conducted using 6-well culture dishes. HeLa cells were
passed at least 12 hours prior to all transfection experiments. HeLa cells expressing bovine miR-181a were
transfected with NPM2 plasmid (1 μg) or pcDNA3.1 vector (1 μg) using FuGene® 6 transfection reagent (Roche
Applied Science, Indianapolis, IN) according to the manufacturer’s instructions. Control Hela cells not expressing
bovine miR181a were also transfected with NPM2
plasmid or pcDNA3.1 vector. Twenty-four hours posttransfection, all cells were harvested by trypsinization.
Cell pellets were lysed in cell lysis buffer (100 mM
sodium b-glycerophosphate, 20 mM HEPES, 15 mM
MgCl2, 5 mM EGTA, 100 mM 4-amidinophenylmethylsulfonyl fluoride, 3 mg/ml leupeptin, and 10 mg/ml aprotinin, pH 7.5) followed by sonication using an Ultrasonic
Homogenizer (BioLogics, Manassas, VA). Western blot
analysis of NPM2 protein expression in these cells was
performed using anti-bovine NPM2 antibody as described
above. Detection of GAPDH (protein loading control)
was performed using anti-GAPDH antibody (Ambion,
Austin, TX). Density of the protein bands was determined using a densitometer and NPM2 protein expression was normalized with GAPDH.

Preparation of expression constructs

The plasmid expressing bovine NPM2 was constructed
by cloning of the full length bovine NPM2 cDNA into
pcDNA3.1 expression vector (Invitrogen, Carlsbad, CA).
PCR primers (Additional file 1, Table S1) containing
BamHI (forward) and XhoI (reverse) restriction sites
were designed to amplify the full length bovine NPM2
cDNA using a fetal ovary cDNA sample (230 days of
gestation). The amplified PCR product was cloned using
TOPO® TA cloning kit (Invitrogen, Carlsbad, CA) followed by subcloning into the BamHI and XhoI sites of
pcDNA3.1. The plasmid designed to express the bovine
miR-181a was prepared by cloning a 262 bp genomic
fragment containing the pre-miR-181a into pcDNA3.1.
Primers containing BamHI (forward) and PmeI (reverse)
restriction sites (Additional file 1, Table S1) were used
to amplify the 262 bp DNA fragment from kidney genomic DNA. Following TA cloning the product was cloned
into the BamHI and PmeI sites of pcDNA3.1. Both constructs were sequenced to ensure that no mutations
were introduced during PCR amplification.
Cell culture and transfection experiments

HeLa cells from ATCC (Manassas, VA) were grown at
37°C in a humidified incubator containing 5% CO2 in
Dulbecco’s modified Eagle’s medium (DMEM; Invitrogen,
Carlsbad, CA) supplemented with 10% fetal bovine serum
(FBS) and 1% penicillin-streptomycin. Stable HeLa cells
expressing bovine miR-181a was generated by transfecting the cells with miRNA-181a plasmid followed by selection in G418. Transfection experiments (n = 5) were

Statistics

Differences in expression of NPM2 mRNA and protein
and miRNA-181a between samples were analyzed by
GLM procedures of SAS with LS means (SAS 9.1.3, SAS
Institute Inc., Cary, NC). Different letters indicate significant differences (P < 0.05).

Results and discussion
cDNA cloning and tissue distribution of bovine NPM2

The complete cDNA sequence (851 bp) for bovine
NPM2 was obtained by assembly of the sequences from
the PCR and RACE fragments (Figure 1A). The
sequence has been deposited in GenBank (accession
number: FJ769182). BLAST search of the bovine reference genome sequence in the NCBI database using the
bovine NPM2 cDNA did not find the corresponding
gene sequence. However, a previous bovine chromosome 8 genomic contig sequence (NW_932049) in GenBank database contains the NPM2 gene which spans
~14.6 kb. Alignment of the cDNA with the genomic
sequence using the NCBI Splign program [27] revealed
that the bovine NPM2 gene contains 9 exons separated
by 8 introns (Figure 1B). Visual inspection of the promoter region identified 2 putative E-boxes (cacctg)
located approximately 200 bp upstream of the predicted
transcription start site (data not shown). Such elements
are known to be responsible for oocyte-specific gene
expression [28,29].
The bovine NPM2 cDNA encodes a protein of 200
amino acids. Analysis of the predicted NPM2 protein
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Figure 1 Cloning and sequence analysis of bovine NPM2 gene. A. Schematic representation of bovine NPM2 cDNA and its cloning strategy.
B. Schematic representation of bovine NPM2 gene structure. C. Multiple alignment of the deduced amino acid sequence of bovine NPM2 with
its human and mouse counterparts. Alignment of amino acid sequences from human (NP_877724), mouse (NP_851990) and bovine (ACT65735)
NPM2 proteins was performed using ClustalW analysis [42]. The area indicated by the box is the nuclear localization signal. The stars in the
alignment represent the putative histone binding region [a stretch of negatively charged glutamic acid (E) and aspartic acid (D) residues].

sequence revealed that it contains a conserved bipartite
nuclear localization signal (KRLAPQKQTSAAKEKK),
and a series of glutamic and aspartic residues (E and D)
implicated in binding histones and protamines (Figure
1C). The protein shows 53% and 62% amino acid
sequence identity with the mouse and human NPM2,
respectively (Figure 1C).
To determine the tissue distribution of the bovine
NPM2 gene, RT-PCR was performed using RNA samples isolated from multiple bovine tissues. As shown in
Figure 2, expression of bovine NPM2 mRNA was
restricted to adult and fetal ovaries, which is consistent

with the result of Northern blot analysis to detect
mouse Npm2 expression [6].
Expression of bovine NPM2 mRNA and protein in oocytes
and early embryos

Expression of NPM2 mRNA in bovine oocytes (GV and
MII stage) and early embryos (pronuclear, 2-cell, 4-cell,
8-cell, 16-cell, morula and blastocyst stage) was investigated by quantitative real time PCR. The results indicate
that NPM2 mRNA is most abundant in GV and MII
stage oocytes relative to early embryos. The abundance
of mRNA for NPM2 is decreased in embryos at
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bNPM2
RPL19
Figure 2 Tissue distribution of bovine NPM2 mRNA. Expression of NPM2 mRNA in various bovine tissues including liver, lung, thymus, kidney,
muscle, heart, spleen, cortex, pituitary, adrenal, testis, ovary, fetal testis and fetal ovary was determined by RT-PCR analysis. Bovine ribosomal
protein L19 (RPL19) was used as a positive control for RNA quality and RT.

pronuclear and 2-cell stage, is further decreased from
4-cell to 16-cell stages, reaching a level that is barely
detectable in morula and blastocyst stage embryos
(Figure 3A; P < 0.05). Abundance of bovine NPM2 protein in GV and MII stage oocytes as well as in 2-cell,
16-cell and blastocyst stage embryos was evaluated by
Western blot analysis. As shown in Figure 3B, the protein is abundant in GV and MII stage oocytes and
remains fairly abundant in 2-cell and 16-cell stage

embryos but drops sharply by the blastocyst stage. The
immunoreactive protein band for bovine NPM2 protein
is approximately 30 kDa which is similar to the size of
mouse NPM2 protein (32 kDa) [30] but larger than predicted size of ~22 kDa. Sumoylation of the protein
could be a cause for this discrepancy as the protein contains a sumoylation consensus motif (ΨKXE). The
expression pattern of bovine NPM2 mRNA and protein
during early embryogenesis is very similar to a number

Figure 3 Expression of bovine NPM2 mRNA and protein during oocyte maturation and early embryonic development. A. Real time PCR
analysis of bovine NPM2 mRNA expression during in vitro oocyte maturation and early embryogenesis (mean ± SEM, n = 4 pools of oocytes or
embryos). The oocytes and embryo samples used in the experiment included GV- and MII-stage oocytes, pronuclear (PN), 2-cell (2C), 4-cell (4C),
8-cell (8C), 16-cell (16C), morula (MO)-stage, and blastocyst (BL)-stage embryos. Data were normalized relative to abundance of GFP RNA
(exogenous control). Different letters indicate statistical difference (P < 0.05). B. Determination of bovine NPM2 protein expression in GV- and MIIstage oocytes, and early embryos at 2-cell, 16-cell and blastocyst stage by Western blot analysis using anti-bovine NPM2 antibodies.
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Expression of bovine NPM2 mRNA is decreased in
oocytes from persistent follicles

Results of numerous studies indicate that competence or
quality of oocytes harvested from persistent dominant
follicles is poor [32,33]. For example, embryos derived
from oocytes obtained from persistent dominant follicles
underwent embryonic death in vivo by the 16-cell stage
[34]. Our previous experiments demonstrated that
mRNA abundance for genes (MSY2, PARN and YY1)
important for early embryogenesis was significantly
lower in oocytes obtained from persistent versus growing dominant follicles [24]. As NPM2 is a key oocytespecific nuclear factor essential for early embryonic
development, the relative abundance of bovine NPM2
mRNA in oocytes from growing (day 6) and persistent
follicles (day 13) was determined by real time PCR. The
results indicate that the level of bovine NPM2 mRNA
is significantly lower in oocytes from persistent
versus growing dominant follicles (P < 0.05) (Figure 4),
supporting a potential relationship between NPM2
mRNA abundance and oocyte competence. This result
is also consistent with results in rainbow trout where
low-quality eggs were shown to have lower levels of
NPM2 transcript [35]. It is likely that insufficient oocyte
store of NPM2 mRNA results in decreased ability of
oocyte to perform sperm chromatin remodeling at fertilization which is essential for early embryogenesis. As
the expression of NPM2 is associated with oocyte quality, it could potentially serve as a marker for oocyte
developmental competence. The relationship between
oocyte quality and NPM2 mRNA abundance merits
further investigation in other models of oocyte quality.
Evidence of translational silencing of bovine NPM2 by
miR-181a

Based on the expression pattern of bovine NPM2
mRNA during early embryonic development and recent
evidence indicating the involvement of miRNAs in regulation of maternal RNA [15-17], it was hypothesized

10

Relative abundance of NPM2 mRNA

of known bovine maternal effect genes essential for early
embryonic development [18,19,21,22] and suggests
maternal origin of this factor. Furthermore, NPM2
mRNA abundance in 8-cell embryos was not diminished
by culture in the presence of the transcriptional inhibitor alpha-amanitin (data not shown) indicating that the
NPM2 mRNA detected in the early bovine embryos is
maternal/oocyte derived. Although the NPM2 mRNA
was significantly reduced by the 16-cell stage, the protein level did not decrease until after the 16-cell stage
(Figure 3B), indicating that NPM2 may be required for
nuclear reorganization in embryos through the time
of embryonic genome activation in cattle at the 8- to
16-cell stage [31].
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Figure 4 Determination of NPM2 mRNA abundance in oocytes
from growing and persistent dominant follicles by quantitative
real time PCR analysis (mean ± SEM, n = 4). Bovine HIST2H2AA4
gene was used as an endogenous control for data normalization.
Relative abundance of NPM2 mRNA is significantly lower in oocytes
from persistent than from growing follicles. Different letters indicate
statistical difference (P < 0.05).

that NPM2 might be targeted by miRNAs for silencing
and/or degradation during early embryogenesis. Potential miRNA binding sites in the 3’UTR of bovine NPM2
mRNA were predicted using MicroInspector [36], an
algorithm for detection of possible interactions between
miRNAs and target mRNA sequences [37]. A miR-181a
binding site in bovine NPM2 3’UTR was identified
(Figure 5A). Alignment of the 3’UTR sequence for
bovine NPM2 mRNA with the human and mouse orthologous sequences revealed that the “seed” sequence of
the binding site, corresponding to the most important
region for miRNA:mRNA interactions, was conserved in
all aligned sequences (Figure 5B).
An initial experiment was conducted using real time
PCR to determine if miR-181a is expressed in oocytes
and early embryos. As shown in Figure 6, miR-181a is
present in all stages of oocytes and early embryos examined. There appears to be an increase in miR-181 in
oocytes during the transition from GV to MII stage. Following a drop in 2-cell stage embryos, the level of miR181a increases again in embryos at 4-cell to 16 cell
stage, a period corresponding to the time of embryonic
genome activation in cattle when expression of NPM2
decreases gradually. The inverse correlation between
miR-181a and NPM2 expression during early embryogenesis further supports our hypothesis that NPM2
might be down-regulated by miR-181a.
To test if miR-181a regulates NPM2 protein expression in the context of its native mRNA sequence, coexpression studies using a construct containing the full
length bovine NPM2 cDNA and a plasmid designed to
deliver bovine miR-181a were performed. Western blot
analysis using antibodies against bovine NPM2 showed

Lingenfelter et al. Reproductive Biology and Endocrinology 2011, 9:40
http://www.rbej.com/content/9/1/40

Page 7 of 9

A
  )(("')
"""""(8*$$8*8
******************
((("(""$&88$&$

 ')()


B

%&'(  """"" " " """"" !
%&'( """"" "" " "" """ "  " """ """" '
%&'( "" "
" " " " """  """"  " "  " #'



%&'( """" "  "    "" "" """ " """"""
%&'(  """""" """"   "  ""  """ """" """""""!#
%&'(  """"""""""" 
      "  """  """""" "" '

miR-181a binding site



%&'(  " "" " """" " "" "" 
"
" 
%&'(  " """
"""""" """""" " ""  ""  "!
%&'(  """ "  """"""" """ """ 
"  "'

******

Figure 5 Prediction of a miR-181a binding site in the 3’-UTR of NPM2 cDNA. A. Predicted miR-181a binding site in bovine NPM2 3’-UTR.
B. Alignment of the 3’-UTR sequences from human, mouse and bovine NPM2 cDNA sequences (alignment was performed using ClustalW
analysis). The outlined box indicates the conserved miR-181a binding site.

that expression of bovine NPM2 protein was reduced
in cells expressing miR-181a compared to control cells
without miR-181a (Figure 7A, the minor band present
is all samples apparently is a non-specific signal).
Quantification of NPM2 protein expression using densitometry (Figure 7B) confirmed that co-expression
with miR-181a decreased the level of NPM2 protein

(P < 0.05), indicating that translation of NPM2 is
repressed by miR-181a.
miR-181a is a conserved miRNA that has been identified in diverse species. Recent studies have suggested
that miR-181a may function as a tumor suppressor in
cancer cells [38] or a modulator of cisplatin-induced
cancer cell death [39]. It has also been reported that
miR-181a down regulates the expression of zinc finger
(ZNF) genes by targeting the sequences coding for the
ZNF C2H2 domain [40]. The involvement of miR-181a
in regulating the expression of NPM2 supports a new
role of this miRNA in early embryonic development.
Specific miRNAs known to be responsible for maternal
mRNA degradation have been reported in zebrafish [17]
and Xenopus [41]. However, in mammals, specific miRNAs targeting maternal effect genes have not been
reported. This study represents the first report of a specific miRNA potentially involved in regulation of a
maternal effect gene in mammalian species.

Figure 6 Quantitative real-time PCR analysis of miR-181a
expression in oocytes and early embryos (mean ± SEM, n = 3).
The oocytes and embryo samples in the experiment included GVand MII-stage oocytes, 2-cell (2C), 4-cell (4C), 8-cell (8C), 16-cell
(16C), morula (MO)-stage, and blastocyst (BL)-stage embryos.
Quantity of miR-181a was normalized to miR-125b. Different letters
indicate statistical difference (P < 0.05).

Conclusions
Our data suggest that bovine NPM2 present in early
embryos is of maternal origin and NPM2 is positively
associated with oocyte developmental competence.
Results also demonstrate suppression of NPM2 translation by miR-181a and suggest that expression of this
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Figure 7 Western blot analysis of NPM2 protein expression in Hela cells transfected with NPM2 and miR-181a expression plasmids. A.
A representative Western blot showing suppression of NPM2 protein in cells expressing miR-181a. B. Densitometric analysis of protein bands on
the Western blots. Data were normalized to GAPDH and expressed as relative pixel density (mean ± SEM, n = 5). Different letters indicates
statistical significance (P < 0.05).

essential nuclear factor during early embryogenesis is
potentially regulated by miR-181a.

Additional material
Additional file 1: Table S1: List of primers used in the study.
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